Precision Medicine

New PIGN Gene Duplication Identified in Rare MCAHS1 Syndrome
Research & Development New PIGN Gene Duplication Identified in Rare MCAHS1 Syndrome

The discovery of a recurring 'AGGTG' microhomology sequence at the duplication breakpoints suggests that specific DNA repair mechanisms are responsible for these complex PIGN gene disruptions. This finding represents a significant leap in our understanding of Multiple Congenital

PC-Based Control Drives Innovation in Personalized Medicine
Tech & Innovation PC-Based Control Drives Innovation in Personalized Medicine

Transitioning to a software-defined laboratory model allows researchers to change scientific protocols without making major mechanical overhauls. The global pharmaceutical industry is currently witnessing an unprecedented pivot from mass-market pharmaceutical blockbusters to highly targeted genetic

City of Hope and Adagene Launch Trial for Colorectal Cancer
Research & Development City of Hope and Adagene Launch Trial for Colorectal Cancer

Advancing Immunotherapy in the Global Oncology Landscape The current trajectory of global oncology research is defined by a rigorous departure from generalist treatments toward sophisticated, molecularly targeted therapies that prioritize long-term patient survival over temporary remission. In

Nigerian Breast Cancer Patients Ready for Genetic Testing
Research & Development Nigerian Breast Cancer Patients Ready for Genetic Testing

While approximately 95.7 percent of Nigerian breast cancer patients express readiness for genetic testing, the vast majority have a mean correct response rate of only 20.5 percent regarding recognized risk factors. The epidemiological landscape of Nigeria has undergone a profound transformation as

Isomorphic Labs Secures Five Billion Dollars for AI Drug Design
Tech & Innovation Isomorphic Labs Secures Five Billion Dollars for AI Drug Design

The pharmaceutical industry has long grappled with the 'Eroom’s Law' phenomenon, where the cost of developing a new drug doubles approximately every nine years despite major technological advances, making the quest for efficiency a matter of global health survival. This struggle has reached a

Closing the Equity Gap in Cancer Care Through Precision Medicine
Tech & Innovation Closing the Equity Gap in Cancer Care Through Precision Medicine

Legislative progress in 25 states has mandated biomarker testing coverage, yet many patients still face prohibitive cost-sharing requirements and frequent insurance denials for innovative modalities. The promise of precision medicine—the tailoring of medical treatment to the individual

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later